Nigel J. Temperton

ਸਿੱਖਿਅਤ ਹੋਏ: University of Kent

ਕਾਰੋਬਾਰ: ਖੋਜੀ

ਅਧਿਕਾਰਤ ਵੈੱਬਸਾਈਟ: www.scienceopen.com/search#author/7dfcb465-9bb4-4228-baf8-3869f08899c5

Series

There is nothing here

Create a new serie

Works

There is nothing here

Create a new work

Articles 94

Date

ਸਿਰਲੇਖ

ਲੇਖਕ

2022-05-20

Potent cross-reactive antibodies following Omicron breakthrough in vaccinees

Nigel J. Temperton
2022-07-08

Fatal COVID-19 outcomes are associated with an antibody response targeting epitopes shared with endemic coronaviruses

Jonathan Ball, David Eyre, Philip Hopkins, Cesar Lopez-Camacho, Sheila Lumley, Alexander J Mentzer, Nicholas M Provine, Jeremy D Ratcliff, Nigel J. Temperton, Duncan Wyncoll, Peter Simmonds, Teresa Lambe, Malcolm G. Semple, Peter Openshaw, Uri Obolski, Gavin R Screaton, Stephen H Kennedy, Eleanor J. Barnes, Susanna Dunachie, Philippa C Matthews, Tihana Bicanic, Paul Klenerman, Craig P Thompson, Miles W Carroll
2022-11-15

Antibody correlates of protection from SARS-CoV-2 reinfection prior to vaccination: A nested case-control within the SIREN study

Ashley D. Otter, Michael Howell, Nigel J. Temperton, Caio Vinicius Tranquillini, Michelle Cole, Colin S Brown, Maria Zambon, Susan Hopkins, Tim Brooks
2022-05-23

Further antibody escape by Omicron BA.4 and BA.5 from vaccine and BA.1 serum

Donal T Skelly, Nigel J. Temperton, Gavin R Screaton, Eleanor J. Barnes
2021-02-05

SARS-CoV-2 evolution during treatment of chronic infection

Kendra E Leigh, Aminu S Jahun, Dami Collier, Marit J. van Gils, Theodore Gouliouris, Effrossyni Gkrania-Klotsas, Nigel J. Temperton
2021-03-11

Sensitivity of SARS-CoV-2 B.1.1.7 to mRNA vaccine-elicited antibodies

Alexandra Walls, Antonio Lanzavecchia, John E Bowen, William T Harvey, Dami Collier, Davide Corti, Nigel J. Temperton
2021-02-15

SARS-CoV-2 B.1.1.7 sensitivity to mRNA vaccine-elicited, convalescent and monoclonal antibodies

Dora Pinto, Alexandra Walls, Joseph Chappell, Antonio Lanzavecchia, Dami Collier, Nigel J. Temperton
2021-11-27

The antibody response to SARS-CoV-2 Beta underscores the antigenic distance to other variants

Helen M E Duyvesteyn, Alexander J Mentzer, Beibei Wang, Donal T Skelly, Thomas G Ritter, Nigel J. Temperton, Neil G Paterson, David R Hall, Gavin R Screaton
2020-04-17

Neutralising antibodies to SARS coronavirus 2 in Scottish blood donors - a pilot study of the value of serology to determine population exposure

Bridget S Penman, Lian Ni Lee, Valerie Odon, Juthathip Mongkolsapaya, Senthil Chinnakannan, Kreepa Kooblall, Narayan Ramamurthy, Jeremy D Ratcliff, John Kenneth Baillie, Gavin R Screaton, Nigel J. Temperton, Paul Klenerman, ਸੁਨੇਤਰਾ ਗੁਪਤਾ, Peter Simmonds, Heli Harvala
2020-08-21

Evaluation of a Pseudotyped Virus Neutralisation Test for the Measurement of Equine Influenza Virus-Neutralising Antibody Responses Induced by Vaccination and Infection

Nigel J. Temperton, Janet Daly, Romain Paillot, Simon D. Scott
2020-09-10

Characterisation of SARS-CoV-2 Lentiviral Pseudotypes and Correlation between Pseudotype-Based Neutralisation Assays and Live Virus-Based Micro Neutralisation Assays

Inesa Hyseni, Pietro Piu, Nigel J. Temperton, Emanuele Montomoli
2020-10-26

Longitudinal observation and decline of neutralizing antibody responses in the three months following SARS-CoV-2 infection in humans

Jeffrey Seow, Blair Merrick, Sam Acors, Suzanne Pickering, Rui Pedro Galao, Harry Wilson, Adrian W Signell, Jose M Jiménez-Guardeño, Nigel J. Temperton, Luke Blagdon Snell, Lauren Martinez, Brielle Stokes, Alba Izquierdo-Barras, Amita Patel, Tan Kia Ik Mark, Geraldine O'Hara, Manu Shankar-Hari, Michael Henry Malim, Katie Doores, Aoife M O'Byrne, Stuart Neil, Sam T Douthwaite, Rocio T Martinez-Nunez, Batra Rahul, Eithne MacMahon, Neophytos Kouphou, Gilberto Betancor, Karen Bisnauthsing, Gaia Nebbia
2020-12-14

Development of immunohistochemistry and in situ hybridisation for the detection of SARS-CoV and SARS-CoV-2 in formalin-fixed paraffin-embedded specimens

Fabian Zx Lean, Mart M. Lamers, Nigel J. Temperton, Bart L. Haagmans, Kevin Bewley, Sharon M Brookes, Debby Schipper, Miles W Carroll
2020-12-01

Discordant neutralizing antibody and T cell responses in asymptomatic and mild SARS-CoV-2 infection

Catherine J Reynolds, Leo Swadling, Joseph M Gibbons, Corinna Pade, Melanie Peta Jensen, Mariana O Diniz, Nathalie Schmidt, David K Butler, Oliver E Amin, Sasha N L Bailey, Sam M Murray, Franziska P Pieper, Stephen Taylor, Jessica Jones, Meleri Jones, Wing-Yiu Lee, Joshua Rosenheim, Aneesh Chandran, George Joy, Cecilia Di Genova, Nigel J. Temperton, Jonathan Lambourne, Teresa Cutino-Moguel, Mervyn Andiapen, Marianna Fontana, Angelique Smit, Amanda Semper, Ben O'Brien, Benny Chain, Tim Brooks, Charlotte Manisty, Thomas A Treibel, James Moon, Mahdad Noursadeghi, Daniel Altmann, Mala K Maini, Áine McKnight, Rosemary Boyton
2019-01-04

The MHC class-II HLA-DR receptor mediates bat influenza A-like H17N10 virus entry into mammalian cells

George William Carnell, Efstathios S Giotis, Michael A. Skinner, Nigel J. Temperton, Wendy Barclay
2019-02-20

Identification of Broad-Spectrum Antiviral Compounds by Targeting Viral Entry

Ana Maria Ortega-Prieto, Joe Grove, Edward Wright, Nigel J. Temperton, Mark Marsh, Michela Mazzon, Jessica Katy Skelton
2019-02-10

Cross-Reactive and Lineage-Specific Single Domain Antibodies against Influenza B Hemagglutinin

George William Carnell, Nigel J. Temperton, Othmar G Engelhardt
2019-11-08

Humoral Immunogenicity and Efficacy of a Single Dose of ChAdOx1 MERS Vaccine Candidate in Dromedary Camels

Anwar M Hashem, Nigel J. Temperton, Sarah Gilbert, Teresa Lambe, Esam I Azhar
2019-07-29

Entry of the bat influenza H17N10 virus into mammalian cells is enabled by the MHC class II HLA-DR receptor

Efstathios S Giotis, George William Carnell, Erik F. Young, Saleena S Ghanny, Lin-Fa Wang, Michael A. Skinner, Nigel J. Temperton, Wendy Barclay
2018-02-05

Integrase Defective Lentiviral Vector as a Vaccine Platform for Delivering Influenza Antigens.

Nigel J. Temperton, Alessandra Gallinaro, Martina Borghi, Maria Fenicia Vescio, Mirella Salvatore, Zuleika Michelini, Andrea Cara, Donatella Negri, Serena Cecchetti
2018

Cross-Protective Immune Responses Induced by Sequential Influenza Virus Infection and by Sequential Vaccination With Inactivated Influenza Vaccines

Nigel J. Temperton, Othmar G Engelhardt, Jacqueline de Vries-Idema, Kate Guilfoyle, Tjarko Meijerhof, Anke Huckriede, Cornelis A. M. de Haan
2018-09-21

A naturally protective epitope of limited variability as an influenza vaccine target

Duncan S Palmer, George William Carnell, Daniel O'Connor, José Lourenço, Thomas A. Bowden, Nigel J. Temperton, ਸੁਨੇਤਰਾ ਗੁਪਤਾ, Sarah Gilbert, Oliver G. Pybus, Andrew Pollard, Teresa Lambe
2018-07-10

Production of lentiviral vectors pseudotyped with influenza neuraminidase (NA) v1 (protocols.io.rkkd4uw)

Nigel J. Temperton, Emanuele Montomoli
2018-05-31

Cross-protective immune responses induced by sequential influenza virus infection and by sequential vaccination with inactivated influenza vaccines

Nigel J. Temperton, Othmar G Engelhardt, Jacqueline de Vries-Idema, Kate Guilfoyle, Tjarko Meijerhof, Anke Huckriede
2018-01-22

Pseudotype Neutralization Assays: From Laboratory Bench to Data Analysis

Francesca Ferrara, Nigel J. Temperton
2018

A Lentiviral Pseudotype ELLA for the Measurement of Antibodies Against Influenza Neuraminidase

Nigel J. Temperton, Emanuele Montomoli
2018-12-10

Development and use of Lentiviral Vectors Pseudotyped with Influenza B Haemagglutinins: application to vaccine immunogenicity, mAb potency and sero-surveillance studies

Francesca Ferrara, George William Carnell, Simon D. Scott, Nigel J. Temperton, Paul Kellam, Sarah Gilbert
2017-03-01

Epidemiology of herpes simplex virus type 1 and 2 in Italy: a seroprevalence study from 2000 to 2014.

Nigel J. Temperton
2017-07-19

Novel Bivalent Viral-Vectored Vaccines Induce Potent Humoral and Cellular Immune Responses Conferring Protection against Stringent Influenza A Virus Challenge

Nigel J. Temperton, Sarah Gilbert, Senthil Chinnakannan, Francesca Ferrara, Teresa Lambe
2017-06-01

ChAdOx1 and MVA based vaccine candidates against MERS-CoV elicit neutralising antibodies and cellular immune responses in mice

Nigel J. Temperton, Megan A Sloan, Daniel Wells, Sarah Gilbert, Craig P Thompson, Adrian V. S. Hill, Teresa Lambe, George M Warimwe, Naif Khalaf Alharbi
2017-09-25

The Use of Hyperimmune Chicken Reference Sera Is Not Appropriate for the Validation of Influenza Pseudotype Neutralization Assays

Nigel J. Temperton, Francesca Ferrara
2017-11-13

The study of antibody responses to influenza neuraminidase using a lentiviral pseudotype based ELLA

George William Carnell, Nigel J. Temperton, Emanuele Montomoli

Human - wd:Q39614751

Welcome to Inventaire

the library of your friends and communities

learn more